Regeneron Pharmaceuticals
The Oncology Imaging Scientific Lead will lead the strategy and execution of complex early and late phase oncology imaging in clinical trials, with a special focus on PET and CT modalities. This role involves developing imaging biomarkers, supporting scientific imaging aspects, and overseeing tumor response assessment for oncology clinical studies. The position requires collaboration with cross-functional program teams, including Regeneron clinical and preclinical colleagues as well as external academic and industry partners.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
17% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Clinical Imaging Scientist Translational Radiology Waltham Massachusetts United States Of America
AstraZeneca
Global Head of Radiology & Theranostics
AstraZeneca
Director, Imaging Biomarkers
Dyne Therapeutics
Clinical Imaging Scientist, Translational Radiology
AstraZeneca
Director, Scientific Engagement
Perceptive
Director, Translational Imaging Lead
City of Duncan, Oklahoma